05/2023

• Qiming News

  Qiming's Nisa Leung and Duane Kuang Made 2023 Forbes Midas List

04/2023

• Portfolio News

  Zai Lab and MediLink Therapeutics Announced Strategic Partnership for a Next Generation Antibody-Drug Conjugate Program in Oncology

• Portfolio News

  Qiming Venture Partners' portfolio company MedSci successfully listed on HKEX main board

• Portfolio News

  Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901

• Qiming News

  Qiming Monthly Newsletter (March 2023)

03/2023

• Portfolio News

  Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq

• Portfolio News

  World's First Quadrivalent COVID-19 Vaccine Developed by SinocellTech is Approved for Emergency Use in China

• Portfolio News

  Qiming Venture Partners led two consecutive funding rounds in next-generation precision medicine company Allorion Therapeutics

• Portfolio News

  Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing

• Qiming News

  Qiming Monthly Newsletter (February 2023)

• Portfolio News

  TandemAI Raises $35 Million in Series A Financing Led by Qiming Venture Partners

02/2023

• Portfolio News

  Qiming Venture Partners' Portfolio Company LanzaTech Lists on Nasdaq

• Portfolio News

  Qiming Venture Partners Celebrates Hesai Technology's IPO on Nasdaq

• Portfolio News

  Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq

• Qiming News

  Qiming Monthly Newsletter (January 2023)

01/2023

• Portfolio News

  China's Leading Adult Interest Learning Service Provider QuantaSing Group Limited Successfully Listed on Nasdaq

• Qiming News

  Qiming Venture Partners 14th CEO Summit successfully concluded

• Qiming News

  Qiming Monthly Newsletter (December 2022)

12/2022

• Qiming News

  Qiming Venture Partners to Hold the 14th CEO Summit This Week

• Qiming News

  Qiming Venture Partners to Hold the 14th CEO Summit This Week

• Qiming News

  Merry Christmas!

• Qiming News

  Qiming Venture Partners to Hold the 14th CEO Summit

• Portfolio News

  SinocellTech's Recombinant Protein COVID-19 Vaccine SCTV01C Approved for Emergency Use in China

• Portfolio News

  CanSinoBIO's Convidecia Air™ at a Glance

• Qiming News

  Qiming Monthly Newsletter (November 2022)

11/2022

• Qiming News

  Qiming Venture Partners Wins 2022 AVCJ Fundraising of the Year - VC Award

• Portfolio News

  Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion

• Qiming News

  Qiming Monthly Newsletter (October 2022)

10/2022

• Portfolio News

  The Case Report of Belief BioMed’s Hemophilia B Gene Therapy Drug Candidate BBM-H901 Published in The New England Journal of Medicine

• Portfolio News

  CANbridge Announced Encouraging Development in Maralixibat in Rare Liver Disease

• Portfolio News

  WeRide and Hyundai Plan to Fuel Self-driving with Hydrogen in China

• Portfolio News

  OriCell's GPRC5D CAR-T Received Orphan Drug Designation from FDA

• Portfolio News

  CanSinoBIO Celebrates the Rollout of Inhaled Vaccine Convidecia Air™ in Shanghai

• Qiming News

  Qiming Insights | Qiming’s Kan Chen on Scientist Entrepreneurship in Healthcare

• Portfolio News

  Abbisko Obtained Phase III Clinical Trial Approval for ABSK021 from CDE of NMPA

• Portfolio News

  TigerGraph Announced Commitment to Support openCypher in GSQL

• Portfolio News

  Qiming Venture Partners' portfolio Transwarp successfully lists on STAR Market

• Portfolio News

  CANbridge in Oral Presentation at ESGCT 29th Annual Congress

• Portfolio News

  AmoyDx and BeiGene Announced Strategic Cooperation on HER2 Companion Diagnostics

• Portfolio News

  Jacobio Pharma Announced a Clinical Trial Collaboration Agreement with Merck

• Qiming News

  Qiming’s Duane Kuang Awarded Fortune China’s 2022 TOP 30 Most Influential Investors in China

• Qiming News

  Qiming's Grace Lee Awarded TOP 10 China VC/PE CFO in 2022

• Qiming News

  Qiming Monthly Newsletter (September 2022)

• Portfolio News

  Antengene Announced Upcoming Presentations at SITC 2022

• Portfolio News

  Ark Biopharmaceutical Presented Positive Results at 12th International RSV Symposium

• Portfolio News

  Schrödinger Forged a Drug Design Collaboration with Eli Lilly

• Portfolio News

  CanSinoBIO to Present Latest Data at the World Vaccine Congress Europe 2022

• Portfolio News

  dMed-Clinipace Announced Corporate Name Change to Caidya

09/2022

• Qiming News

  Nisa Leung on Reuters: 'Overinvested' China Healthcare Sector Set for Shake Up

• Portfolio News

  Zai Lab and Seagen Announced Regional Strategic Collaboration and License Agreement

• Qiming News

  Oscar Zhang Shared with BioWorld on Recent Funding of Koutech

• Qiming News

  Qiming's Nisa Leung Awarded 2021 Leader of the Year

• Portfolio News

  Surgical Robot Platform Company Koutech Nets Hundreds of Mns of RMB in Series A Round

• Portfolio News

  OriCell Therapeutics Receives Implied License from NMPA for Ori-C101 IND Application

• Portfolio News

  Insilico Medicine Clinches an Award at the HKB Technology Excellence Awards

• Portfolio News

  Antengene Announces ATG-101 Granted Orphan Drug Designation by the U.S. FDA

• Portfolio News

  Naked Eye 3D Microscope First Presented at ESE by Bondent Group

• Portfolio News

  Roborock Ranks First among Robot Vacuum Makers Globally in Terms of Sales Volume

• Portfolio News

  Genor Biopharma's GB261 Phase I/II Clinical Trial is Officially Launched in China

• Portfolio News

  Insta360 Announced 360 Action Cam X3 That Makes Magic Out of the Action